Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mahdi Shabani, Jila Naseri & Fazel Shokri. (2015) Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy. Expert Opinion on Therapeutic Targets 19:7, pages 941-955.
Read now
Read now
Therese Högfeldt, Abeer A. Bahnassy, Anna Kwiecinska, Anders Österborg, Katja Pokrovskaja Tamm, Anna Porwit, Abdel-Rahman N. Zekri, Joachim Lundahl, Hussein M. Khaled, Håkan Mellstedt & Ali Moshfegh. (2013) Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures. Leukemia & Lymphoma 54:5, pages 996-1003.
Read now
Read now
Iman Shaheen & Noha Ibrahim. (2012) Detection of Orphan Receptor Tyrosine Kinase (ROR-1) Expression in Egyptian Pediatric Acute Lymphoblastic Leukemia. Fetal and Pediatric Pathology 31:3, pages 113-119.
Read now
Read now
Articles from other publishers (31)
Amineh Ghaderi, Wen Zhong, Mohammad Ali Okhovat, Johanna Aschan, Ann Svensson, Birgitta Sander, Johan Schultz, Thomas Olin, Anders Österborg, Mohammad Hojjat-Farsangi & Håkan Mellstedt. (2022) A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells. Pharmaceutics 14:10, pages 2238.
Crossref
Crossref
Eileen Y. Hu, Priscilla DoSwagata Goswami, Jessica Nunes, Chi-ling Chiang, Sara Elgamal, Ann M. Ventura, Carolyn Cheney, Kevan Zapolnik, Erich Williams, Rajeswaran Mani, Frank Frissora, Xiaokui MoLorenz Waldmeier, Roger R. Beerli, Haiyong PengChristoph Rader, Meixiao Long, Ulf Grawunder, John C. Byrd & Natarajan Muthusamy. (2021) The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia. Blood Advances 5:16, pages 3152-3162.
Crossref
Crossref
Claudio Ortolani. 2021. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies
301
427
.
Mohammad Hojjat-Farsangi, Ali Moshfegh, Johan Schultz, Martin Norin, Thomas Olin, Anders Österborg & Håkan Mellstedt. 2021. Pharmacology of the WNT Signaling System. Pharmacology of the WNT Signaling System
75
99
.
Majid Ghayour-Mobarhan, Amir Sadra Zangouei, Seyed Mohammad Hosseinirad, Majid Mojarrad & Meysam Moghbeli. (2020) Genetics of blood malignancies among Iranian population: an overview. Diagnostic Pathology 15:1.
Crossref
Crossref
Masumeh Galini, Mehdi Salehi, Maciej Kubicki, Mehdi Bayat & Rahime Eshaghi Malekshah. (2020) Synthesis, structural characterization, DFT and molecular simulation study of new zinc-Schiff base complex and its application as a precursor for preparation of ZnO nanoparticle. Journal of Molecular Structure 1207, pages 127715.
Crossref
Crossref
Xiaojun Ding & Xiaoshu Zhu. (2019) Locating potentially lethal genes using the abnormal distributions of genotypes. Scientific Reports 9:1.
Crossref
Crossref
Yuan Mao, Li Xu, Jun Wang, Louqian Zhang, Nan Hou, Juqing Xu, Lin Wang, Shu Yang, Yan Chen, Lin Xiong, Jin Zhu, Weifei Fan & Jiaren Xu. (2019) ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway. BioFactors 45:3, pages 416-426.
Crossref
Crossref
Marilynn Chow, Lina Gao, Jason D. MacManiman, Vincent T. Bicocca, Bill H. Chang, Joshi J. Alumkal & Jeffrey W. Tyner. (2018) Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL. Oncogene 37:38, pages 5221-5232.
Crossref
Crossref
Hadi Hassannia, Mohammad Mehdi Amiri, Farhad Jadidi-Niaragh, Reza Hosseini-Ghatar, Jalal Khoshnoodi, Ramezan-Ali Sharifian, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani & Fazel Shokri. (2018) Inhibition of tumor growth by mouse ROR1 specific antibody in a syngeneic mouse tumor model. Immunology Letters 193, pages 35-41.
Crossref
Crossref
Leili Aghebati-Maleki, Vahid Younesi, Behzad Baradaran, Jalal Abdolalizadeh, Morteza Motallebnezhad, Hamid Nickho, Dariush Shanehbandi, Jafar Majidi & Mehdi Yousefi. (2017) Antiproliferative and Apoptotic Effects of Novel Anti-ROR1 Single-Chain Antibodies in Hematological Malignancies. SLAS Discovery 22:4, pages 408-417.
Crossref
Crossref
Xiao-Ying Zhang & Pei-Ying Zhang. (2016) Receptor tyrosine kinases in carcinogenesis. Oncology Letters 12:5, pages 3679-3682.
Crossref
Crossref
Natalia Brenda Fernández, Daniela Lorenzo, María Elisa Picco, Gastón Barbero, Leonardo Sebastián Dergan-Dylon, María Paula Marks, Hernán García-Rivello, Liliana Gimenez, Vivian Labovsky, Luca Grumolato & Pablo Lopez-Bergami. (2016) ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway. Molecular Carcinogenesis 55:11, pages 1772-1785.
Crossref
Crossref
Abdul Salam Khan, Mohammad Hojjat-Farsangi, Amir Hossein Daneshmanesh, Lotta Hansson, Parviz Kokhaei, Anders Österborg, Håkan Mellstedt & Ali Moshfegh. (2016) Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia. Tumor Biology 37:9, pages 11947-11957.
Crossref
Crossref
Archana Jayaraman, Kaiser Jamil & Haseeb A. Khan. (2015) Identifying new targets in leukemogenesis using computational approaches. Saudi Journal of Biological Sciences 22:5, pages 610-622.
Crossref
Crossref
Jia L. Song, Priya Nigam, Senel S. Tektas & Erica Selva. (2015) microRNA regulation of Wnt signaling pathways in development and disease. Cellular Signalling 27:7, pages 1380-1391.
Crossref
Crossref
Abbas Ali Imani Fooladi, Hamideh Mahmoodzadeh Hosseini & Jafar Amani. (2015) An In silico Chimeric Vaccine Targeting Breast Cancer Containing Inherent Adjuvant. Iranian Journal of Cancer Prevention 8:3.
Crossref
Crossref
Yanchun Liu, Hui Yang, Tianxing Chen, Yongbin Luo, Zheyuan Xu, Ying Li & Jiahui Yang. (2015) Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma. PLOS ONE 10:5, pages e0127092.
Crossref
Crossref
Mitsuharu Endo, Michiru Nishita, Ryosuke Doi, Makoto Hayashi & Yasuhiro Minami. 2015. Receptor Tyrosine Kinases: Family and Subfamilies. Receptor Tyrosine Kinases: Family and Subfamilies
593
640
.
Mohammad Hojjat-Farsangi, Ali Moshfegh, Amir Hossein Daneshmanesh, Abdul Salam Khan, Eva Mikaelsson, Anders Österborg & Håkan Mellstedt. (2014) The receptor tyrosine kinase ROR1 – An oncofetal antigen for targeted cancer therapy. Seminars in Cancer Biology 29, pages 21-31.
Crossref
Crossref
Caroline E. Ford, Sean Si Qian Ma, Ashfaque Quadir & Robyn L. Ward. (2013) The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis. International Journal of Cancer 133:4, pages 779-787.
Crossref
Crossref
Hema Dave, Miriam R. Anver, Donna O. Butcher, Patrick Brown, Javed Khan, Alan S. Wayne, Sivasubramanian Baskar & Christoph Rader. (2012) Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies. PLoS ONE 7:12, pages e52655.
Crossref
Crossref
Sabrina Uhrmacher, Christina Schmidt, Felix Erdfelder, Simon Jonas Poll-Wolbeck, Iris Gehrke, Michael Hallek & Karl-Anton Kreuzer. (2011) Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL). Leukemia Research 35:10, pages 1360-1366.
Crossref
Crossref
Timothy W. FarrenJerome GiustinianiFeng-Ting LiuDimitris A. TsitsikasMarion G. MaceyJames D. CavenaghHeather E. OakerveeDavid TaussigAdrian C. NewlandMaria Calaminici, Armand Bensussan, Michael JennerJohn G. GribbenSamir G. Agrawal. (2011) Differential and tumor-specific expression of CD160 in B-cell malignancies. Blood 118:8, pages 2174-2183.
Crossref
Crossref
Lin Wang, Juxiang Huang, Minghu Jiang & Lingjun Sun. (2010) MYBPC1 Computational Phosphoprotein Network Construction and Analysis between Frontal Cortex of HIV encephalitis (HIVE) and HIVE-Control Patients. Cellular and Molecular Neurobiology 31:2, pages 233-241.
Crossref
Crossref
Michael HudecekThomas M. SchmittSivasubramanian BaskarMaria Teresa Lupo-StanghelliniTetsuya NishidaTori N. YamamotoMarie Bleakley, Cameron J. TurtleWen-Chung Chang, Harvey A. GreismanBrent WoodDavid G. MaloneyMichael C. Jensen, Christoph RaderStanley R. Riddell. (2010) The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. Blood 116:22, pages 4532-4541.
Crossref
Crossref
Natalia Lyashenko, Martina Weissenböck, Amnon Sharir, Reinhold G. Erben, Yasuhiro Minami & Christine Hartmann. (2010) Mice lacking the orphan receptor ror1 have distinct skeletal abnormalities and are growth retarded. Developmental Dynamics 239:8, pages 2266-2277.
Crossref
Crossref
Ping Li, David Harris, Zhiming Liu, Jie Liu, Michael Keating & Zeev Estrov. (2010) Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells. PLoS ONE 5:7, pages e11859.
Crossref
Crossref
Lili MilaniAnders LundmarkAnna KiialainenJessica NordlundTrond FlaegstadErik ForestierMats HeymanGudmundur JonmundssonJukka KanervaKjeld SchmiegelowStefan SöderhällMats G. Gustafsson, Gudmar Lönnerholm & Ann-Christine Syvänen. (2010) DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood 115:6, pages 1214-1225.
Crossref
Crossref
Jeffrey W. TynerMichael W. DeiningerMarc M. LoriauxBill H. ChangJason R. GotlibStephanie G. WillisHeidi EricksonTibor KovacsovicsThomas O'Hare, Michael C. Heinrich & Brian J. Druker. (2009) RNAi screen for rapid therapeutic target identification in leukemia patients. Proceedings of the National Academy of Sciences 106:21, pages 8695-8700.
Crossref
Crossref
Yasuhiro Minami, Isao Oishi, Mitsuharu Endo & Michiru Nishita. (2009) Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: Their implications in developmental morphogenesis and human diseases. Developmental Dynamics, pages NA-NA.
Crossref
Crossref